Delivery Order SPE2DB24D1201-SPE2DB25FJEBP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,096.88 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on August 14, 2025. The contract is classified as firm fixed price with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the company's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound 5 mg/0.5 mL pen injections, valued at $5,504.59. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 28, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $11,527.36 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,927.33 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $19,448.32 delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,051.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-competitive, non-set-aside delivery order represents a pharmaceutical supply requirement fulfilled through AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $10,016.78 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections. This firm fixed price contract, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injections valued at $7,625.80 on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections valued at $9,805.19 on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJEBPDelivery Order
The Defense Logistics Agency awarded a $13,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. The contract, which is set to be completed by September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded competitively without a set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements through open competition. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen's federal contract portfolio with the DLA demonstrates extensive experience fulfilling diverse medical procurement needs, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 9/3/25 |